SCHEMBL17809776

SCHEMBL17809776

CN1CCCc2cc(-c3ccn(C)n3)ccc21

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
WDR5 P61964 1/20 0.53
ALDH1A1 P00352 3/20 0.49
KMT2A Q03164 2/20 0.49
MEN1 O00255 1/20 0.49
GAA P10253 1/20 0.49
MAPT P10636 1/20 0.49
HPGD P15428 1/20 0.49
CREBBP Q92793 3/20 0.43
KEAP1 Q14145 1/20 0.42
NOTUM Q6P988 1/20 0.41
KDM4E B2RXH2 1/20 0.39
MAPK1 P28482 1/20 0.39
HTT P42858 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
PIK3CD O00329 1/20 0.39
PIP5K1C O60331 1/20 0.39
PIK3CA P42336 1/20 0.39
PIK3CB P42338 1/20 0.39
PI4KA P42356 1/20 0.39
PIK3CG P48736 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17806211 0.83 NOTUM (0.44) WDR5ALDH1A1KMT2AMAPTHPGD
SCHEMBL17809555 0.77 ALDH1A1 (0.47) WDR5ALDH1A1KMT2AMEN1GAA
SCHEMBL17809770 0.77 WDR5 (0.51) WDR5ALDH1A1KMT2AMEN1GAA
SCHEMBL17809559 0.77 WDR5 (0.51) WDR5ALDH1A1KMT2AMEN1GAA
SCHEMBL17795410 0.77 CREBBP (0.54) WDR5ALDH1A1KMT2AMEN1GAA
SCHEMBL17809554 0.76 WDR5 (0.50) WDR5ALDH1A1KMT2AMEN1GAA
SCHEMBL17809581 0.76 WDR5 (0.50) WDR5ALDH1A1KMT2AMEN1GAA
SCHEMBL17794936 0.76 WDR5 (0.47) WDR5ALDH1A1KMT2AMEN1GAA
SCHEMBL17809619 0.76 WDR5 (0.60) WDR5ALDH1A1KMT2AMEN1GAA
SCHEMBL17809574 0.76 ALDH1A1 (0.51) WDR5ALDH1A1KMT2AMEN1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3224258-B1 4,5,6,7-TETRAHYDRO-1H-PYRAZOLO[4,3-C]PYRIDIN-3-AMINE COMPOUNDS AS CBP AND/OR EP300 INHIBITORS GENENTECH INC (US) 2019-08-14 EP disclosed
US-20170333406-A1 THERAPEUTIC COMPOUNDS AND USES THEREOF GENENTECH, INC. (US) 2017-11-23 US disclosed
US-9763922-B2 Therapeutic compounds and uses thereof GENENTECH, INC. (US) 2017-09-19 US disclosed
US-20160158207-A1 THERAPEUTIC COMPOUNDS AND USES THEREOF GENENTECH, INC. (US) 2016-06-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170333406-A1 THERAPEUTIC COMPOUNDS AND USES THEREOF EP300, HDAC1, HDAC10 WDR5 621/4885ALDH1A1 1727/4885KMT2A 315/4885
US-20160158207-A1 THERAPEUTIC COMPOUNDS AND USES THEREOF EP300, HDAC1, HDAC10 WDR5 621/4885ALDH1A1 1727/4885KMT2A 315/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.